Oseltamivir Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

 Oseltamivir Market size is forecast to reach $694.3 million by 2025, growing at a CAGR of 3.17% during the forecast period 2020-2025. Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. It helps make the symptoms like stuffy nose, cough, sore throat, fever/chills, aches, and tiredness less severe and shortens the recovery time by 1-2 days. Oseltamivir acts as neuraminidase inhibitor of the influenza virus, by preventing its reproduction by budding from the host cell. This also prevents the cleavage of sialic acid residues, thus interfering with progeny virus disbursement within the mucosal secretions and reducing viral infectivity. Growing incidences of influenza among the population, increasing awareness about the prevention, and increasing investments in novel drug combinations by big investment firms are major factors that are driving the market growth in recent years. In addition, major developments by key market players like Alembic Pharmaceuticals are other factors driving the growth of the market. 


Report Coverage

The report: “Oseltamivir Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Oseltamivir Market. 

By Formulation: Capsule, Powder
By Indication: Influenza A, Influenza B
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
By Geography: North America, Europe, Asia-Pacific, Rest of the World (RoW)


Key Takeaways

  • North America dominated the Oseltamivir Market in the year 2019 owing to large number of cases of the population infected with influenza, increasing healthcare affordability of the majority population and government initiatives, presence of key market players in the region and funds for better innovations in the drug market. The Oseltamivir Market scope for different regions will be provided in the final report.
  • Rising numbers of influenza cases among the population, increasing awareness programs about the prevention and treatment of influenza, and increasing investments in novel drug combinations by big investment firms and key players in the market have helped in significant growth of Oseltamivir Market. 
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Oseltamivir Market report.
  • Side effects of Oseltamivir is anticipated to hamper the market growth of the Oseltamivir Industry.


Indication - Segment Analysis

Influenza A held the largest share in the indication segment of Oseltamivir Market in 2019 and is estimated to grow at a CAGR of 2.71% during the forecast period 2020-2025. Factors that contribute to the growth of this segment are the increasing prevalence of the disease and recent FDA approval of products by various companies for oral and other forms of dosage for influenza A. Also, spread of influenza A in other living beings (compared to influenza B which occurs only in human beings), and more severe reactions have led to demand for more and better medication by Oseltamivir drug, hence fueling market growth. Influenza B held the second largest share in the market, owing to a large percentage of influenza patients being affected by influenza B and more preference to Oseltamivir for its treatment. Influenza A segment is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to major investments in medications for treatment of Influenza A by key market players.


Distribution Channels - Segment Analysis

Hospital Pharmacies segment held the major share in the distribution channels segment of Oseltamivir Market in 2019. Specialty drugs spend, next-door healthcare, increased focus on 340B performance and compliance, tracking and managing data and public policy with greater transparency are driving the market growth of this segment. Online Pharmacies segment is forecast to continue growing at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to growing trends in digital services and favorable government policies for online retails of medicines.

Comments

Popular posts from this blog

Printed Tape Market - Forecast(2021 - 2026)

Pet Care Market - Forecast(2021 - 2026)

Occupant Classification System Market - Forecast(2021 - 2026)